M H Silber

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi Current management of sleep disturbances in dementia
    Bradley F Boeve
    Mayo Sleep Disorders Center, Department of Neurology, Mayo Alzheimer s Disease Research Center, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Curr Neurol Neurosci Rep 2:169-77. 2002
  2. ncbi Narcolepsy, head injury, and the problem of causality
    Michael H Silber
    Department of Neurology and Sleep Disorders Center, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    J Clin Sleep Med 1:157-8. 2005
  3. ncbi An algorithm for the management of restless legs syndrome
    Michael H Silber
    Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
    Mayo Clin Proc 79:916-22. 2004
  4. ncbi The visual scoring of sleep in adults
    Michael H Silber
    Mayo Sleep Disorders Center, Mayo Clinic College of Medicine, Rochester, MN 55902, USA
    J Clin Sleep Med 3:121-31. 2007
  5. doi Willis-Ekbom Disease Foundation revised consensus statement on the management of restless legs syndrome
    Michael H Silber
    Center for Sleep Medicine and Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
    Mayo Clin Proc 88:977-86. 2013
  6. doi Sleep-related movement disorders
    Michael H Silber
    Mayo Clinic, Department of Neurology, 200 1st Street SW, Rochester, MN 55905, USA
    Continuum (Minneap Minn) 19:170-84. 2013
  7. ncbi Multiple blood donations associated with iron deficiency in patients with restless legs syndrome
    Michael H Silber
    Sleep Disorders Center, Department of Mayo Clinic, Rochester, Minn 55905, USA
    Mayo Clin Proc 78:52-4. 2003
  8. ncbi Complex nocturnal visual hallucinations
    Michael H Silber
    Sleep Disorders Center, Mayo Clinic College of Medicine, 200 1st Street SW, Rochester, MN 55905, USA
    Sleep Med 6:363-6. 2005
  9. ncbi Clinical practice. Chronic insomnia
    Michael H Silber
    Sleep Disorders Center and the Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minn 55902, USA
    N Engl J Med 353:803-10. 2005
  10. ncbi Pramipexole in the management of restless legs syndrome: an extended study
    Michael H Silber
    Sleep Disorders Center, Mayo Clinic, Rochester, MN 55905, USA
    Sleep 26:819-21. 2003

Detail Information

Publications47

  1. ncbi Current management of sleep disturbances in dementia
    Bradley F Boeve
    Mayo Sleep Disorders Center, Department of Neurology, Mayo Alzheimer s Disease Research Center, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Curr Neurol Neurosci Rep 2:169-77. 2002
    ....
  2. ncbi Narcolepsy, head injury, and the problem of causality
    Michael H Silber
    Department of Neurology and Sleep Disorders Center, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    J Clin Sleep Med 1:157-8. 2005
  3. ncbi An algorithm for the management of restless legs syndrome
    Michael H Silber
    Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
    Mayo Clin Proc 79:916-22. 2004
    ..The role of carbidopa/levodopa, dopamine agonists, opioids, benzodiazepines, and anticonvulsants for the different types of the disorder is delineated...
  4. ncbi The visual scoring of sleep in adults
    Michael H Silber
    Mayo Sleep Disorders Center, Mayo Clinic College of Medicine, Rochester, MN 55902, USA
    J Clin Sleep Med 3:121-31. 2007
    ..Movement time was eliminated and major body movements defined. Studies are needed to test the reliability of the new rules. Future advances in technology may require modification of these rules with time...
  5. doi Willis-Ekbom Disease Foundation revised consensus statement on the management of restless legs syndrome
    Michael H Silber
    Center for Sleep Medicine and Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
    Mayo Clin Proc 88:977-86. 2013
    ..We discuss the available drugs, the factors determining which to use, and their adverse effects. We define refractory RLS/WED and describe management approaches, including combination therapy and the use of high-potency opioids. ..
  6. doi Sleep-related movement disorders
    Michael H Silber
    Mayo Clinic, Department of Neurology, 200 1st Street SW, Rochester, MN 55905, USA
    Continuum (Minneap Minn) 19:170-84. 2013
    ..This article reviews the sleep-related movement disorders, including restless legs syndrome (RLS; Willis-Ekbom disease), periodic limb movement disorder, rhythmic movement disorders, sleep-related bruxism, and sleep-related leg cramps...
  7. ncbi Multiple blood donations associated with iron deficiency in patients with restless legs syndrome
    Michael H Silber
    Sleep Disorders Center, Department of Mayo Clinic, Rochester, Minn 55905, USA
    Mayo Clin Proc 78:52-4. 2003
    ..To describe a series of patients with restless legs syndrome (RLS) and iron deficiency with and without anemia related to repeated blood donations...
  8. ncbi Complex nocturnal visual hallucinations
    Michael H Silber
    Sleep Disorders Center, Mayo Clinic College of Medicine, 200 1st Street SW, Rochester, MN 55905, USA
    Sleep Med 6:363-6. 2005
    ..To describe the clinical features and associations of complex nocturnal visual hallucinations...
  9. ncbi Clinical practice. Chronic insomnia
    Michael H Silber
    Sleep Disorders Center and the Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minn 55902, USA
    N Engl J Med 353:803-10. 2005
  10. ncbi Pramipexole in the management of restless legs syndrome: an extended study
    Michael H Silber
    Sleep Disorders Center, Mayo Clinic, Rochester, MN 55905, USA
    Sleep 26:819-21. 2003
    ....
  11. ncbi Sleep disorders
    M H Silber
    Mayo Medical School, and Mayo Clinic, Rochester, Minnesota 55905, USA
    Neurol Clin 19:173-86. 2001
    ..Arousal parasomnias can be treated with behavioral methods such as hypnosis and drug therapy. Clonazepam provides relief of the symptoms in most patients with REM sleep behavior disorder...
  12. ncbi The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study
    Michael H Silber
    Sleep Disorders Center, Department of Neurology, Mayo Clinic and Mayo Medical School, Rochester, Minnesota 55905, USA
    Sleep 25:197-202. 2002
    ..To determine the age- and sex-specific incidence rates and prevalence of narcolepsy in a United States community...
  13. pmc Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder
    B F Boeve
    Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
    Sleep Med 14:754-62. 2013
    ..To determine the pathologic substrates in patients with rapid eye movement (REM) sleep behavior disorder (RBD) with or without a coexisting neurologic disorder...
  14. pmc REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century
    D O Claassen
    Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN, USA
    Neurology 75:494-9. 2010
    ..Idiopathic REM sleep behavior disorder (RBD) may be the initial manifestation of synucleinopathies (Parkinson disease [PD], multiple system atrophy [MSA], or dementia with Lewy bodies [DLB])...
  15. ncbi Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy
    B F Boeve
    Sleep Disorders Center and Department of Neurology, Mayo Clinic Rochester, Rochester, Minnesota 55905, USA
    Mov Disord 16:622-30. 2001
    ..In the setting of degenerative dementia and/or parkinsonism, we hypothesize that RBD is a manifestation of an evolving synucleinopathy...
  16. ncbi Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease
    B F Boeve
    Department of Neurology, 6Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Brain 130:2770-88. 2007
    ..Furthermore, longitudinal studies in patients with idiopathic RBD are warranted to characterize the natural history of such patients and prepare for future therapeutic trials...
  17. ncbi Narcolepsy: new understanding of irresistible sleep
    L E Krahn
    Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minn 55905, USA
    Mayo Clin Proc 76:185-94. 2001
    ..This article reviews the current understanding of the diagnosis and treatment of narcolepsy and discusses the possible implications of the hypocretin discovery...
  18. pmc Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies
    T J Ferman
    Department of Psychiatry and Psychology, Mayo Clinic, Jacksonville, FL 32224, USA
    Neurology 77:875-82. 2011
    ..To determine whether adding REM sleep behavior disorder (RBD) to the dementia with Lewy bodies (DLB) diagnostic criteria improves classification accuracy of autopsy-confirmed DLB...
  19. ncbi REM sleep behavior disorder and dementia: cognitive differences when compared with AD
    T J Ferman
    Department of Psychiatry and Psychology, Mayo Clinic and Foundation, Rochester, MN, USA
    Neurology 52:951-7. 1999
    ....
  20. ncbi Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists
    M Tippmann-Peikert
    Mayo Clinic Sleep Disorders Center, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Neurology 68:301-3. 2007
    ..We report three patients treated in our sleep disorders center who developed pathologic gambling while receiving treatment with dopamine agonists for restless legs syndrome...
  21. ncbi Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism
    B F Boeve
    Department of Neurology, Mayo Clinic, Rochester, Minneapolis, MN 55905, USA
    Neurology 61:40-5. 2003
    ..To determine if synucleinopathy pathology is related to REM sleep behavior disorder (RBD) plus dementia or parkinsonism...
  22. pmc History of the development of sleep medicine in the United States
    John W Shepard
    Sleep Disorders Center, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    J Clin Sleep Med 1:61-82. 2005
    ....
  23. ncbi Cataplexy Emotional Trigger Questionnaire (CETQ)--a brief patient screen to identify cataplexy in patients with narcolepsy
    Wendy R Moore
    Sleep Disorders Center, Department of Nursing, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    J Clin Sleep Med 3:37-40. 2007
    ..We hypothesized that the brief questionnaire could provide a quick, sensitive, and specific screening tool to identify those patients with cataplexy, which would result in more timely referrals for further diagnostic testing...
  24. ncbi Dementia with Lewy bodies may present as dementia and REM sleep behavior disorder without parkinsonism or hallucinations
    Tanis J Ferman
    Department of Psychiatry and Psychology, Mayo Clinic and Foundation, Jacksonville, Florida 32224, USA
    J Int Neuropsychol Soc 8:907-14. 2002
    ..This provides further evidence in support of including RBD as one of the core diagnostic features of DLB...
  25. ncbi Effect of a targeted obstructive sleep apnea consult to improve access and quality at a sleep disorders center
    Timothy I Morgenthaler
    Mayo Clinic Sleep Disorders Center, 200 First Street SW, Rochester, MN 55905, USA
    J Clin Sleep Med 2:49-56. 2006
    ....
  26. ncbi Analysis of hypocretin (orexin) antibodies in patients with narcolepsy
    John L Black
    Psychogenomics Laboratory, Department of Psychiatry and Psychology, Mayo Clinic College of Medicine, Rochester, MN, USA
    Sleep 28:427-31. 2005
    ..We tested the hypothesis that patients with narcolepsy have serum antibodies specific for preprohypocretin and its derivatives...
  27. ncbi Studies of humoral immunity to preprohypocretin in human leukocyte antigen DQB1*0602-positive narcoleptic subjects with cataplexy
    John L Black
    Psychogenomics Laboratory, Department of Psychiatry and Psychology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Biol Psychiatry 58:504-9. 2005
    ..We tested the hypothesis that DQB1*0602-positive narcoleptic subjects with cataplexy have immunoglobulin (Ig)G reactive to human preprohypocretin and its cleavage products...
  28. pmc The treatment of parasomnias with hypnosis: a 5-year follow-up study
    Peter J Hauri
    Sleep Disorders Center, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    J Clin Sleep Med 3:369-73. 2007
    ..This study involves a replication and extension of a previous one reported by Hurwitz et al (1991) on the treatment of certain parasomnias with hypnosis...
  29. ncbi Neurophysiologic studies in Morvan syndrome
    Keith A Josephs
    Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
    J Clin Neurophysiol 21:440-5. 2004
    ..The absence of abnormalities on imaging studies suggests that central nervous system symptoms are related to functional rather than structural disruption of neural networks...
  30. ncbi Childhood-onset restless legs syndrome
    Suresh Kotagal
    Division of Child and Adolescent Neurology, Mayo Clinic, Rochester, MN, USA
    Ann Neurol 56:803-7. 2004
    ..02). We conclude that iron deficiency and a strong family history are characteristic of childhood-onset restless legs syndrome...
  31. ncbi Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status
    Lois E Krahn
    Mayo Clinic, Department of Psychiatry and Psychology, Rochester, MN 55905, USA
    Sleep 25:733-6. 2002
    ..5%) and more specifically with patients with cataplexy who are HLA DQB1*0602 positive (95.7%). The relationship between hypocretin-1 levels and narcolepsy without cataplexy or the DQB1*0602 allele is less clear...
  32. ncbi REM sleep behavior disorder in Parkinson's disease and dementia with Lewy bodies
    Bradley F Boeve
    Sleep Disorders Center, Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    J Geriatr Psychiatry Neurol 17:146-57. 2004
    ..The evolving data suggests that RBD may have clinical diagnostic and pathophysiologic significance in isolation and when associated with neurodegenerative disease...
  33. ncbi Pergolide in the management of restless legs syndrome: an extended study
    M H Silber
    Sleep Disorders Center, Mayo Clinic, Rochester, Minnesota, USA
    Sleep 20:878-82. 1997
    ..Tolerance did not develop. We conclude that pergolide is an effective second-line agent for RLS, especially following levodopa-induced daytime augmentation...
  34. ncbi Narcolepsy associated with other central nervous system disorders
    S Malik
    Sleep Disorders Center, Mayo Clinic, Rochester, MN 55905, USA
    Neurology 57:539-41. 2001
    ..When they occur together, narcolepsy and other CNS disorders frequently emerge at about the same time, suggesting a causative relationship. Hypothalamic-pituitary pathology was the most common association...
  35. pmc Effects of continuous positive airway pressure on stridor in multiple system atrophy-sleep laryngoscopy
    Tomasz J Kuzniar
    Sleep Disorders Center, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    J Clin Sleep Med 5:65-7. 2009
    ..We discuss the possible mechanisms of action of CPAP in MSA-associated stridor...
  36. pmc Insights into REM sleep behavior disorder pathophysiology in brainstem-predominant Lewy body disease
    B F Boeve
    Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN, USA
    Sleep Med 8:60-4. 2007
    ..Additional cases of idiopathic RBD with neuropathologic examination may help clarify which key brainstem structures are involved...
  37. pmc Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study
    Jason R Cornelius
    Center for Sleep Medicine, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Sleep 33:81-7. 2010
    ..To determine the frequency of impulse control disorders (ICDs) with the use of dopaminergic agents in restless legs syndrome (RLS)...
  38. ncbi Risks of high-dose stimulants in the treatment of disorders of excessive somnolence: a case-control study
    R Robert Auger
    Sleep Disorders Center, Mayo Clinic College of Medicine, Rochester, MN, USA
    Sleep 28:667-72. 2005
    ..To ascertain complications associated with high-dose stimulant therapy in patients with narcolepsy or idiopathic hypersomnia...
  39. ncbi Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients
    Bradley F Boeve
    Sleep Disorders Center, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Sleep Med 4:281-4. 2003
    ..To describe the treatment response with melatonin for rapid eye movement (REM) sleep behavior disorder (RBD) associated with other neurologic disorders...
  40. ncbi Multiple skeletal injuries resulting from uncontrolled restless legs syndrome
    Tomasz J Kuzniar
    Sleep Disorders Center, Mayo Clinic, College of Medicine, Rochester, MN 55905, USA
    J Clin Sleep Med 3:60-1. 2007
    ..Iron replacement therapy and changing of her dopamine-agonist medications resulted in almost complete relief of symptoms. Physicians should be aware of the potential for injury in patients with uncontrolled RLS...
  41. ncbi Hypersomnias of central origin
    Timothy J Young
    Sleep Disorders Center, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905, USA
    Chest 130:913-20. 2006
    ..We define the current utility of diagnostic testing, including sleep studies, neuroimaging techniques, and laboratory investigations. New treatment options for hypersomnia are discussed...
  42. ncbi HLA DQB1*0602 positive narcoleptic subjects with cataplexy have CSF lgG reactive to rat hypothalamic protein extract
    John L Black
    Sleep 28:1191-2. 2005
  43. ncbi Calming restless legs
    Michael H Silber
    Sleep 27:839-41. 2004
  44. ncbi An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder
    Wayne A Hening
    Johns Hopkins Sleep Disorders Center, Johns Hopkins Bayview Medical Center, Baltimore, MD, USA
    Sleep 27:560-83. 2004
    ..This paper reviews the literature on levodopa, dopaminergic agonists (pergolide, pramipexole, ropinirole, talipexole, cabergoline, piribidel, DHEC), and other dopaminergic agents (amantadine, selegiline)...
  45. ncbi Characterizing the emotions that trigger cataplexy
    Lois E Krahn
    Mayo Clinic Scottsdale, 13400 E Shea Blvd, Scottsdale, AZ 85259, USA
    J Neuropsychiatry Clin Neurosci 17:45-50. 2005
    ..These selected questions could subsequently be included into screening tools for use with different patient populations...
  46. ncbi Academic sleep centers of the future: an achievable vision
    Michael H Silber
    Sleep 30:244-5. 2007
  47. ncbi Digital analysis and technical specifications
    Thomas Penzel
    Center for Sleep Medicine, Charite Universitatsmedizin Berlin, Berlin, Germany
    J Clin Sleep Med 3:109-20. 2007
    ....